Mesothelioma Pages

June 8, 2011

Mesothelioma treatment found in common culinary spice

Filed under: Treatment,Uncategorized — MesoPages @ 7:13 am

Turmeric is a spice made from rhizomes of a plant in the ginger family, and is often used in cooking to add flavor and color. A recent study by National Center for Vermiculite and Asbestos-Related Cancers—a partnership between Karmanos Cancer Institute and Wayne State University’s Center for Occupational and Environmental Medicine—suggests that turmeric could provide more to the world than culinary flair. Curcumin, a derivative of turmeric, is being tested as a treatment partner for use on mesothelioma cancer.

Mesothelioma is a rare and aggressive cancer affecting protective lining of abdominal organs, most often lung lining. Caused by exposure to toxic carcinogen asbestos, mesothelioma is characterized by a long latency period and short life expectancy following diagnosis. About three thousand Americans and twenty thousand people worldwide each year suffer with mesothelioma while asbestos use continues to go unregulated in many countries. Although there are mesothelioma treatments available—in select medical facilities—which include surgery, chemotherapy and radiation therapy, these focus on alleviating pain and extending patient life expectancy. There is no cure for mesothelioma.

The curcumin study found that on a cellular level, curcumin elevates amounts of apoptosis inducing proteins—proteins that begin a ‘self-destruct’ process in cells. In included cases of mesothelioma in lab mice and humans, higher curcumin doses translated to higher chemotherapy treatment susceptibility.

National Center for Vermiculite and Asbestos-Related Cancers continues to research and study new information and treatments related to asbestos and mesothelioma. With ninety thousand annual, worldwide mesothelioma cases estimated for our near future, new treatment options could not come at a better time.

June 1, 2011

Mesothelioma symposium participants agree on surgical treatment

Filed under: Treatment,Uncategorized — MesoPages @ 10:15 am

The 1st International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, in Santa Monica, CA, just concluded. Doctors, surgeons and medical experts from around the world gathered to listen and share information on mesothelioma treatments and procedures. Specifically, symposium agendas focused on mesothelioma treatments considered radical, and their benefit, or lack there of, for patients.

Mesothelioma is a rare cancer affecting people worldwide. The World Health Organization estimates twenty thousand people suffer from mesothelioma annually and expect that number to rise rapidly if its cause, asbestos exposure, is not stopped or at least greatly curbed.

Asbestos is a type 1 carcinogen known to cause mesothelioma and other severe diseases of the respiratory system.  Asbestos has been used heavily through the world as a construction agent due to its fire resistance and durability. Although relatively safe while contained in stable materials, toxic asbestos fibers can easily become airborne and inhaled, leading to mesothelioma development.

Pleural mesothelioma is a cancer of lung lining. It spreads an irregular pattern of tumors through the mesothelium, protective lining around the lungs, for decades without being detected; often twenty to fifty years will go by without the patient experiencing signs.  During its end stages, mesothelioma exhibits symptoms like that of pneumonia or bronchitis. Once a diagnosis is made, patient life expectancy ranges from six months to several years.

Mesothelioma treatments include surgeries, chemotherapy and radiation therapy. Radical treatment options often include the removal of an entire lung, all affected areas and lymph nodes, and often parts of the heart lining or diaphragm. This procedure, called an extrapleural pneumonectomy (EPP), has been used for decades and shows a 60% complication rate.

Symposium participants gathered and reviewed data from mesothelioma surgery cases in UK and US. According to event chairman, and director of UCLA Mesothelioma Research Program, Dr. Robert B. Cameron, following discussion of the data doctors present unanimously agreed lung removal is not the most beneficial procedure for mesothelioma patients. Practice of EPPs has already been discontinued in UK.

According to conclusions drawn at the symposium, Dr. Cameron said the “preferred surgical procedure” is a pleurectomy—removal of as many tumors and as much affected tissue as can be safely taken without removing any organs. Pleurectomies are often part of palliative patient care, focusing on slowing mesothelioma tumor spread and extending life expectancy.

Dr. Cameron concluded, “The information presented at this Symposium makes an incredibly strong statement that surgical removal of the lung for treatment of malignant pleural mesothelioma should no longer be performed anywhere in the world, just like it has been abandoned already in the U.K.”

May 18, 2011

Study suggests asbestos thwarts body’s defenses while causing mesothelioma

Filed under: Uncategorized — MesoPages @ 6:36 am

A new study by researchers at the Kawasaki School of Medicine in Japan suggests asbestos may not only initiate mesothelioma cancer growth, but it may also inhibit the body’s natural defense against it.

Natural killer (NK) cells are part of the body’s robust immune system. Containing specific proteins that target and destroy invading cell types, NK cells are a main line of defense against viruses and tumors. Researchers suggest asbestos suppresses cytotoxicity, the defense abilities, of NK cells as well as causing the mutative growth that leads to mesothelioma.

Mesothelioma is a rare and aggressive cancer affecting an estimated fifteen to twenty thousand people worldwide each year. Mesothelioma is characterized by a system of irregularly patterned tumors that spread through the mesothelium—lining of abdominal cavities. Pleural mesothelioma is the more common of the two known types and is specific to tumors in lung lining. Peritoneal mesothelioma is less common and affects lining of other organs like the heart or diaphragm.

Both types of mesothelioma are caused by asbestos fibers. Once inhaled into the lungs these toxic fibers can become lodged in healthy tissue, beginning cancerous cell growth, which ultimately leads to mesothelioma. Asbestos continues to be used globally, and often without safety precautions, regardless of its known health risks.

Mesothelioma has a long latency period, typically ranging between twenty and fifty years. During this time patients usually have no idea they are ill—most never knowing they were ever exposed to toxic asbestos fibers. When symptoms do demonstrate they mimic those of bronchitis or pneumonia, making mesothelioma difficult to diagnose. Following a proper diagnosis, patient life expectancy averages eighteen months.

There are mesothelioma treatments available including surgeries, chemotherapy and radiation treatments. These treatments are usually administered in combination and often as palliative care, focusing on patient comfort and quality of life. There is no known mesothelioma cure.

The Japanese study included tests of asbestos administered to tissue samples. After five months of asbestos exposure, tissues showed a decrease in defense ability in present NK cells. Tissue samples taken from mesothelioma patients showed similar results. In one line of testing, after just two weeks of asbestos exposure, NK cells of healthy tissue samples were losing their cancer fighting abilities.

To cross check results, fiberglass was administered in the same way to same tissue types; these tests did not have the same results.

In conclusion, researchers stated: “These results indicate that asbestos has the potential to suppress cytotoxicity of NK cells.  In particular, it is noteworthy that both NK cells from malignant mesothelioma patients and those from a culture… derived from healthy volunteers with asbestos showed the same characteristic of decreased cytotoxicity with low expression of NKp46.”

May 4, 2011

Austrian study considers additional mesothelioma treatment

Filed under: Treatment,Uncategorized — MesoPages @ 6:21 am

A recent study by Austrian researchers is showing temsirolimus, a kinase inhibitor, may be beneficial as a treatment options for malignant mesothelioma. Temsirolimus is currently used in cases of kidney cancer to slow or stop tumor growth. The drug works by targeting mammalian target of rapamycin (mTOR)—a vital protein that regulates cell growth—and blocking its abilities.

The Austrian research team believes temsirolimus may have the same effect on malignant mesothelioma cancer tumors as it does on kidney cancer. When tested, results showed a slowed growth process in mesothelioma tumors following treatment with temsirolimus. Study findings were published in the May issue of Journal of Thoracic Oncology.

Mesothelioma is currently claiming the lives of an estimated twenty thousand people worldwide each year. Mesothelioma is caused by toxic chemical asbestos and is characterized by a long latency period and short life expectancy following diagnosis. Asbestos continues to be used globally; the mesothelioma death rate is expected to rise until asbestos use is greatly curbed or stopped completely.

Professor Walter Berger, PhD, of the Institute of Cancer Research at the Medical University of Vienna says of the rare cancer, “Malignant mesothelioma is a severe human malignancy characterized by a very bad prognosis, with a mean patient survival time of less than one year. This unacceptable situation is mainly caused by late diagnosis combined with a distinct resistance to all forms of systemic therapy available so far. Mesothelioma is frequently caused by asbestos exposure and unfortunately — based on the long latency period — the incidence peak lies, despite the ban on asbestos, still ahead. Consequently, novel therapeutic options for this devastative disease are urgently needed.”

There is no known cure for mesothelioma. Mesothelioma treatments currently include surgery, chemotherapy and radiation therapy. Typically, a combination of these treatments is administered. However, the study showed that malignant mesothelioma cells resistant to commonly used chemotherapy drug cisplatin, will be hypersensitive against temsirolimus. Temsirolimus, therefore, is suggested as a second-line treatment for mesothelioma or a drug to be used in combination with other chemotherapies.

Professor Berger said, “In our preclinical study, published in the JTO, we were able to demonstrate that inhibition of the major oncogene mTOR is active against human mesothelioma especially after development of chemotherapy resistance both in vitro and in vivo. These results suggest the initiation of clinical trials involving mTOR inhibitors as a novel anti-mesothelioma strategy.”

April 27, 2011

Father’s mesothelioma inspires son’s creative fundraiser

Filed under: Uncategorized — MesoPages @ 8:06 am

A young Englishman has a creative plan to raise funds for mesothelioma research. Jamie Menzies intends to cycle across Europe to heighten awareness and donations for the Papworth Hospital, UK’s largest cardiothoracic specialist facility. Menzies’ inspiration for this caring adventure comes from his father’s current struggle with mesothelioma. Menzies’ father was diagnosed with pleural mesothelioma in November and has been receiving treatments at Papworth Hospital.

Pleural mesothelioma is the more common of two types of mesothelioma, and is specific to lung lining. Peritoneal mesothelioma, the less common type, affects tissue lining of the diaphragm, heart and other abdominal organs. Pleural and peritoneal mesothelioma are caused by asbestos fibers which begin a cancerous growth process after being inhaled or ingested. Asbestos exposure often occurs through work-related or on-the-job hazards in industries using or removing materials containing the toxic chemical.

Menzies plans to bike 1,400 miles, beginning at Papworth Hospital in Cambridgeshire. His route takes him through London to Dover, on ferry to Dunkirk, France, to Switzerland and then returning to Papworth. Menzies expects the trip will take about 23 days if he cycles an average of 60 miles daily.

Papworth Hospital treats an average of 22,400 patients each year. Menzies will bike 100 meters for each of these patients. He hopes to raise $4375; his website has already been used to make donations totaling $3600. Local bike shop, BikeTart has gotten involved by sponsoring Menzies ride and donating 5% of sales on any transaction where “Cycle4Papworth” is mentioned. Menzies’ fundraiser is being called, “One man, Two wheels, Three Countries and An Amazing Cause.” Menzies says, “Every penny raised for the charity will go towards their [Papworth's] Mesothelioma fund, being used to research new techniques to tackle Mesothelioma.”

Menzies’ father was hospitalized for a month at the beginning of his treatments at Papworth Hospital in December. He underwent surgeries to aid his breathing by removing fluid from his lungs. Many mesothelioma treatments are available today, including such surgeries, chemotherapy and radiation therapy. However, the search for a cure continues.

Mesothelioma is characterized by a long latency period, often between twenty and fifty years. When symptoms demonstrate, they mimic those of bronchitis and pneumonia, making mesothelioma difficult to diagnose.  Mesothelioma case numbers continue to rise worldwide. The World Health Organization estimates ninety thousand cases annually if asbestos use is not curbed. Prof Julian Peto, of London School of Hygiene and Topical Medicine and the Institute of Cancer Research, says UK has the highest national mesothelioma death rate with over 2000 losses each year.

April 20, 2011

Study suggests an in-depth look at lung tissue will aid in mesothelioma diagnosis

Filed under: Treatment,Uncategorized — MesoPages @ 10:44 am

In a study done by German researchers, results suggest an in depth inspection of lung tissue may aid in early detection of mesothelioma.

Mesothelioma is a rare type of cancer specific to lung lining and linings of other abdominal cavities. It develops over several decades and typically does not show signs or symptoms until twenty to fifty years after development begins. This makes mesothelioma difficult to diagnose. Symptoms mimic those of bronchitis and pneumonia when they do appear, further postponing a proper diagnosis.

Once a patient has been diagnosed with mesothelioma, life expectancy averages eighteen months, although the range may vary from six months to several years. Mesothelioma is an extremely aggressive cancer, heavily taxing patient energy levels and immune system. There are mesothelioma treatments available, the most common include a combination of surgeries, chemotherapy (often administered as a warm chemo-bath through the infected areas) and radiation therapy. Some new studies suggest that radiation therapy necessitating video assisted thoracoscopic surgery (VATS) may not benefit mesothelioma patients as multiple entry wounds are used to locate infected areas which can cause further spreading of the mesothelioma tumors.

In Germany, mesothelioma is also called occupational disease 4105, a reminder of mesothelioma’s common cause, asbestos, which is often an on-the-job or work-related hazard. Asbestos is classified as a type 1 carcinogen by the World Health Organization. Present in countless building and structural components around the world, asbestos poses a threat to health and safety when its fibers and dust are released into the air. This can happen when asbestos containing materials are destroyed, damaged or broken down through simple wear and tear.

Despite its ability to cause mesothelioma, asbestosis and lung cancer, asbestos continues to be used globally, particularly in developing countries where safety precautions are not regulated and health care facilities necessary to diagnose or treat mesothelioma are non-existent.

German researchers who conducted this recent study note that the average latency period for mesothelioma has risen to 42.5 years. Meanwhile, the average age at diagnosis has also risen to 65.5. These numbers confirm that the reality of diagnosing mesothelioma is becoming more challenging; early detection tools are a must if this disease is to be fought. The research team suggest that an in depth look at lung tissue may be the best way.

Published in Recent Results in Cancer Research, the team said, “The decrease of median asbestos burden of the lung in mesothelioma patients results in disease manifestation at a higher age.  Lung dust analyses are a relevant method for the determination of causation in mesothelioma.”

March 30, 2011

Former MLB player passes away after fighting mesothelioma

Filed under: Uncategorized — MesoPages @ 8:29 am

Former Major League Baseball player Charlie Metro has just died after battling with rare cancer mesothelioma. Metro was 91 years old. Although asbestos is known to be the cause of mesothelioma, as well as lung cancers and asbestosis, not much is known about how or when Metro was exposed to the toxic chemical.

In an interview in 2007 Metro reminisced of working summers in the Western Pennsylvania coalmines along side his father, a full time miner. Metro survived a blast that killed seven other workers, to which he said, “And I said ‘To heck with it’ after that.” Perhaps it was these times in the coalmines that provided Metro with eventually fatal asbestos exposure.

The mining industry is well known for asbestos exposures. Workers are often exposed to raw asbestos in situations of limited air supply and ventilation, raising the chance for inhalation of asbestos fibers. Asbestos dust and fibers can also be trapped on clothing, shoes and in hair, and brought home to family members and loved ones.

Having given up on a career in mining, Metro began his baseball career in 1940. He played for the Detroit Tigers before moving into management. Metro worked as a manager, and scout for decades. Always connected with the baseball world, Metro continued to work as a consultant after his retirement.

Mesothelioma affects about three thousand Americans each year. It is grimly characterized by a short life expectancy following diagnosis. Proper diagnosis is difficult to reach for several reasons. Mesothelioma develops over decades, often taking twenty to fifty years to show symptoms. Many mesothelioma patients have no idea they were ever exposed to asbestos so they are unaware that they could possibly be developing mesothelioma. Also, mesothelioma symptoms mimic those of bronchitis and pneumonia, creating opportunities for false diagnoses and further postponing appropriate treatments.

There are two types of mesothelioma, pleural mesothelioma, which affects the lining of the lungs, and peritoneal mesothelioma which affects lining of other abdominal cavities such as the heart. Pleural mesothelioma is the more common of the two. Both pleural and peritoneal mesothelioma are characterized by a system of irregularly patterned malignant tumors.

Mesothelioma treatments are available. Today, health care providers are using a combination of surgeries, chemotherapy and radiation therapy to treat mesothelioma. However, there is no known mesothelioma cure. Many patients are choosing a regime of palliative care that focuses on better breathing, pain management and quality of life without fighting the cancer directly.

March 23, 2011

Researchers discover new information about mesothelioma development

Filed under: Uncategorized — MesoPages @ 9:10 am

Italian researchers have set a new record for most in-depth study of mesothelioma. Using synchrotron soft x-ray imaging and florescence microscopy scientists were able to take a closer look at the cause, formation and development of mesothelioma tumors.

Mesothelioma is a rare cancer affecting about three thousand Americans each year and an estimated twenty thousand worldwide. Mesothelioma rates are expected to rise as its main cause, toxic chemical asbestos, continues to be used worldwide. At the current rate of unprotected asbestos use, a peak in mesothelioma and related respiratory illnesses is inevitable. In spite if being considered an ‘orphan disease’ because it affects less than two hundred thousand people at a time, mesothelioma receives much attention from researchers and scientists who are working to find a cure for this aggressive cancer.

Asbestos is the known cause of mesothelioma. Once inhaled asbestos dust and fibers begin a mutative process in lung lining and lining in of other abdominal cavities. This begins growth of irregularly patterned tumors, which characterize malignant mesothelioma. Most commonly undetected for twenty to fifty years, mesothelioma has a long latency period. When symptoms do demonstrate they mimic those of pneumonia and bronchitis, making this disease very difficult to diagnose.

Mesothelioma patients may not know they were ever exposed to asbestos, giving them no cause for concern. Once proper diagnosis is made, life expectancy ranges between six months and five years. There are mesothelioma treatments available; surgery, chemotherapy and radiation therapy are all used to fight mesothelioma. Palliative treatments are also available for patients who choose to focus on pain management and quality of life.

Italian researchers found that the iron content in asbestos fibers may be the body to react by trying to isolate the foreign matter. Tissues surrounding asbestos fibers build a ‘pod’ around the area called an ‘asbestos body.’ These bodies are characteristic of mesothelioma and similar cancers.

The researchers report having “revealed the location, distribution and elemental composition of asbestos bodies and associated nanometric structures.” Magnesium may be a part of the ‘asbestos body’ building process as affected areas tested high for the substance. Silicon was also found in high counts close to the fibers.

In an article in Particle and Fibre Toxicity journal, the researchers report, “The new results obtained by simultaneous structural and chemical analysis of tissue specimens have provided clear evidence that magnesium, in addition to iron, is also involved in the formation mechanisms of asbestos bodies.”

March 16, 2011

Fish oil may aid in mesothelioma treatments

Filed under: Uncategorized — MesoPages @ 7:04 am

A study by the University of Alberta in Edmonton, Canada has tested the effects of fish oil on cancer patients. Specifically, the fish oil was used to maintain healthy body weight during preparation, treatment and recovery from cancer treatments.

Cancer patients consistently struggle to keep up healthy body mass. Not only does the disease fight against patients’ natural support systems, but the strong chemotherapy drugs used against the cancer also tax the patients’ resources. Surgery and other procedures weaken the patient even further, minimizing the natural abilities to fight the disease and handle the treatments. Healing and recovery happens faster in healthy patients, and cancerous tissues respond better to chemotherapy in a healthy body.

Mesothelioma patients are one group that would greatly benefit from healthier body weight during treatment. Mesothelioma is a rare respiratory cancer that takes years to develop. By the time it has been diagnosed patients immune systems and regular functions have been greatly taxed. Loss of body mass furthers the weakness and can hinder potentially good responses to treatment.

Mesothelioma is caused by asbestos fibers which can be inhaled or ingested after becoming airborne. These fibers are found in countless materials and components used across the world in industries such as construction, fuel refining, shipbuilding and munitions manufacturing. Although asbestos is relatively safe when it is contained, if it becomes disturbed and dust and fibers escape, there is a great potential health threat.

The University of Alberta study based its approach on the fact that a healthy diet and overall good patient health was a heavy indicator of treatment response and disease control. Keeping up patients body weight could potentially help save lives.

The study included forty patients diagnosed with non small-cell lung cancer. Sixteen of these were given fish oil while twenty-four comprised the control group. A daily does of 2.2 grams of fish oil was given to those sixteen patients to aid in maintaining “weight and muscle mass during chemotherapy.”

Results showed that sixty-nine percent of patients receiving daily fish oil gained or maintained muscle mass, while only twenty-nine percent of those not receiving fish oil did the same.

Patient health is vital for all cancer patients before, during and after treatments. Mesothelioma patients are often diagnosed later in life as the disease is characterized by a latency period of twenty to fifty years. Mesothelioma treatments usually include several rounds of surgery, chemotherapy and radiation therapy—a lot for a patient to endure. The fish oil study may be the beginning of new treatment preparation for the thousands of Americans fighting mesothelioma each year.

March 9, 2011

Mesothelioma patient celebrates more than seven cancer-free years

Filed under: Treatment,Uncategorized — MesoPages @ 7:28 am

An Australian woman is alive and showing no signs of cancer more than seven years after being diagnosed with mesothelioma. After undergoing two rounds of surgery and treatment she joins the very small number of mesothelioma survivors.

Mesothelioma is a rare cancer caused by exposure to asbestos fibers. These fibers, if inhaled, can begin a mutation process in the cells of abdominal cavity lining, developing into irregularly patterned malignant tumors. Mesothelioma takes decades to demonstrate signs and symptoms, often between twenty and fifty years. Once symptoms begin to show they are often mistaken for those of pneumonia or bronchitis.

The Journal of Medical Case Reports included an article covering the details of the Australian woman’s mesothelioma case. At age 40, she sought a physician’s care for abdominal pain, fatigue and a bad taste in her mouth. Tumors were found by CT scan and surgery was performed.

The lady was diagnosed with peritoneal mesothelioma, the less common of two mesothelioma types. Pleural mesothelioma affects lung lining, while peritoneal mesothelioma is specific to the lining of other abdominal cavities. Tumors had infected her bowel, colon and diaphragm. The tumors were removed and the areas treated by a ‘chemo bath’—soaking the affected places in warm chemotherapy solution.

Chemotherapy baths are a common treatment for mesothelioma. Surgery and radiation therapy are also standard cancer-direct mesothelioma treatments. Patients who have a short life expectancy following diagnosis may opt for palliative care to manage the pain and aid in quality of life. The average life expectancy for mesothelioma patients is eighteen months after diagnosis.

Doctors suggest that the Australian woman’s successful treatments hinge on several factors. Peritoneal mesothelioma is less aggressive than the more common pleural mesothelioma. There had been little spread of tumors and the affected areas were very responsive to chemotherapy. In addition, the lady was at least twenty years younger than the standard mesothelioma patient, giving her body a head start in healing. Researchers are also considering the strong presence of estrogen receptors in the tissues affected by the cancer as another possible factor in her recovery.

Mesothelioma, both pleural and peritoneal, is considered a fatal cancer. Although treatments exist and are used, there is no known cure. Due to its long latency period, many patients have no idea they are ill until years after asbestos exposure; and many patients have no idea they were ever exposed to asbestos. The toxic chemical continues to be used around the world and would take decades to remove from all the buildings, equipment and structures it has been built into over the last century.  Mesothelioma cases are expected to continue rising worldwide.

« Newer PostsOlder Posts »

Powered by WordPress